Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Depreciation and Depletion (2019 - 2025)

AVITA Medical (RCEL) has disclosed Depreciation and Depletion for 5 consecutive years, with $394000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion rose 16.22% year-over-year to $394000.0, compared with a TTM value of $1.6 million through Dec 2025, up 60.0%, and an annual FY2025 reading of $1.6 million, up 60.0% over the prior year.
  • Depreciation and Depletion was $394000.0 for Q4 2025 at AVITA Medical, down from $421000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $421000.0 in Q3 2025 and bottomed at $126000.0 in Q1 2023.
  • Average Depreciation and Depletion over 4 years is $240937.5, with a median of $186500.0 recorded in 2024.
  • The sharpest move saw Depreciation and Depletion crashed 34.44% in 2023, then surged 113.9% in 2025.
  • Year by year, Depreciation and Depletion stood at $270000.0 in 2022, then plummeted by 34.44% to $177000.0 in 2023, then skyrocketed by 91.53% to $339000.0 in 2024, then increased by 16.22% to $394000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for RCEL at $394000.0 in Q4 2025, $421000.0 in Q3 2025, and $400000.0 in Q2 2025.